{"id":55096,"date":"2023-03-22T17:04:19","date_gmt":"2023-03-22T16:04:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/"},"modified":"2023-03-22T17:04:19","modified_gmt":"2023-03-22T16:04:19","slug":"gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/","title":{"rendered":"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n\u2013<b><i> Funding Will Reach Under-Resourced Communities Impacted by the HIV Epidemic as Part of Gilead\u2019s Zeroing In\u2122: Ending the HIV Epidemic Grant Program <\/i><\/b>\u2013<b><i> <\/i><\/b>\n<\/p>\n<p>FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide services to communities disproportionately impacted by HIV in rural areas in the United States. My Brother\u2019s Keeper, based in Ridgeland, Mississippi, will provide technical assistance and capacity building to the organizations funded through this initiative. These grants are part of Gilead\u2019s ongoing Zeroing In\u2122 program to help end the HIV epidemic by supporting organizations working to improve the overall health and wellness of communities most impacted by the HIV epidemic.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/5\/GCP_Primarylarge_1.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg\"><\/a><\/p>\n<p>\nWhile HIV is prevalent in both urban and rural communities in the United States, resources are heavily concentrated in urban centers, and lack of public health infrastructure and heightened stigma in rural communities create barriers of access to necessary care. Gilead selected the grantees due to their strategic, community-driven approaches toward dismantling these systemic barriers that prevent people in rural communities from accessing quality HIV testing and treatment. Through this investment, Zeroing In rural health equity and advancement organizations will build on their progress to strengthen public health infrastructure, address HIV-related stigma and provide important resources to under-resourced populations.\n<\/p>\n<p>\n\u201c<!-- no quote -->Gilead is proud to go where the need is greatest and continue to provide support to organizations that are working to provide integral services to rural communities in the U.S. that have long struggled to receive HIV care,\u201d said Jane Stafford, Executive Director, Public Affairs, Gilead Sciences. \u201c<!-- no quote -->These grants will allow organizations to expand their testing programs, provide their communities with access to necessary resources and fight stigma by promoting a culture of compassion and inclusion. It takes more than medicine to end the HIV epidemic and by supporting these organizations, we\u2019re increasing their capacity to educate communities, change perceptions and provide critical access to healthcare where it\u2019s needed most.\u201d\n<\/p>\n<p>\nThe eight Gilead Zeroing In rural health equity and advancement grantees are:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAlliance Of AIDS Services-Carolina (Raleigh, North Carolina)\n<\/li>\n<li>\nCentral Illinois Friends Inc. (Peoria, Illinois)\n<\/li>\n<li>\nCompassionate Atlanta Inc. (Atlanta, Georgia)\n<\/li>\n<li>\nEmpowering Transgender Services Inc. (Hampton, Virginia)\n<\/li>\n<li>\nHelping Everyone Receive Ongoing Effective Support Inc. (Columbia, Louisiana)\n<\/li>\n<li>\nMy Brother\u2019s Keeper Inc. (Ridgeland, Mississippi)\n<\/li>\n<li>\nPierce County AIDS Foundation (Tacoma, Washington)\n<\/li>\n<li>\nPower Safe Place Resource Center of Virginia (Front Royal, Virginia)\n<\/li>\n<\/ul>\n<p>\n\u201c<!-- no quote -->My Brother\u2019s Keeper is excited to help support the recipients of Gilead\u2019s Zeroing In rural health equity and advancement grants with needed capacity building assistance,\u201d said June Gipson, Ph.D., President and Chief Executive Officer, My Brother\u2019s Keeper. \u201c<!-- no quote -->Ensuring that rural communities have equal access and utilization of HIV prevention, care and supportive services is an integral step in combating inequity in HIV health outcomes. Gilead has long been at the forefront of tackling structural and social barriers to HIV care and treatment, and we are proud to work with them to impact change.\u201d\n<\/p>\n<p>\nLaunched in 2021, the Gilead Zeroing In grant program provides support to organizations whose programs aim to increase the overall health and wellness of communities most impacted by HIV.\n<\/p>\n<p>\n<b><span class=\"bwuline\">About Gilead Sciences<\/span><\/b>\n<\/p>\n<p>\nGilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.\n<\/p>\n<p>\nGilead has promoted equity, particularly healthcare equity, since the company brought its first therapies to the market. Through global partnerships, Gilead\u2019s medicines today reach millions of people in low- and middle-income countries around the world. In the United States, Gilead has committed more than $100 million over 10 years through the COMPASS Initiative<sup>\u00ae<\/sup> to community organizations that are working to combat HIV in the U.S. South. In 2020, Gilead launched the Racial Equity Community Impact Fund to support organizations tackling racial inequities affecting Black communities across the United States.\n<\/p>\n<p>\n<b><span class=\"bwuline\">About the Gilead Zeroing In Grant Program<\/span><\/b>\n<\/p>\n<p>\nZeroing In builds on previous Gilead funding and grant programs, while supporting organizations to increase the overall health and wellness of communities most impacted by HIV and COVID-19. Gilead provides support to organizations whose programs align with international and country-specific goals of the Ending the HIV Epidemic initiative. This includes local community programming and coalition-led proposals from organizations collaborating to end the HIV epidemic in their respective city, state, country or region. Zeroing In programming focuses on comprehensive HIV innovation, digital health innovation, and\/or community outreach and education.\n<\/p>\n<p>\nFor more information on Gilead\u2019s Zeroing In grant program to help end the HIV epidemic, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gilead.com%2Fpurpose%2Fgiving%2Fzeroing-in-ending-hiv-epidemic&amp;esheet=53364997&amp;newsitemid=20230320005679&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.gilead.com%2Fpurpose%2Fgiving%2Fzeroing-in-ending-hiv-epidemic&amp;index=1&amp;md5=045f9a072d68f08ab5a5ab699c563e57\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.gilead.com\/purpose\/giving\/zeroing-in-ending-hiv-epidemic<\/a>.\n<\/p>\n<p class=\"bwalignc\">\n<i>GILEAD, the GILEAD Logo, ZEROING IN and COMPASS INITIATIVE are trademarks of Gilead Sciences, Inc.<\/i>\n<\/p>\n<p class=\"bwalignc\">\n<i>For more information about Gilead, please visit the company\u2019s website at <\/i><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.gilead.com&amp;esheet=53364997&amp;newsitemid=20230320005679&amp;lan=en-US&amp;anchor=www.gilead.com&amp;index=2&amp;md5=5ee981a8cc0154c17ea63c5c6d614f79\" rel=\"nofollow noopener\" shape=\"rect\"><i>www.gilead.com<\/i><\/a><i>, follow Gilead on Twitter (@Gilead Sciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nHayley Home, Media<br \/>\n<br \/><a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#x3a;&#x50;&#x75;&#x62;&#x6c;&#x69;c_A&#102;&#102;&#97;&#105;&#x72;&#x73;&#x40;&#x67;&#x69;&#x6c;ead&#46;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x50;&#x75;&#x62;&#108;&#105;&#99;_A&#x66;&#x66;&#x61;&#x69;&#114;&#115;&#64;g&#x69;&#x6c;&#x65;&#x61;&#100;&#46;co&#x6d;<\/a>\n<\/p>\n<p>\nJacquie Ross, Investors<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#73;&#x6e;&#x76;e&#115;&#116;&#x6f;&#x72;_r&#101;&#x6c;&#x61;&#x74;i&#111;&#x6e;&#x73;&#x40;g&#105;&#108;&#x65;&#x61;d&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#73;&#x6e;v&#x65;s&#116;&#x6f;&#114;&#x5f;r&#101;&#x6c;&#97;&#x74;i&#x6f;&#x6e;&#115;&#x40;g&#x69;l&#101;&#x61;&#100;&#x2e;c&#111;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>\u2013 Funding Will Reach Under-Resourced Communities Impacted by the HIV Epidemic as Part of Gilead\u2019s Zeroing In\u2122: Ending the HIV Epidemic Grant Program \u2013 FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide services to communities disproportionately impacted &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55096","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u2013 Funding Will Reach Under-Resourced Communities Impacted by the HIV Epidemic as Part of Gilead\u2019s Zeroing In\u2122: Ending the HIV Epidemic Grant Program \u2013 FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide services to communities disproportionately impacted ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-22T16:04:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities\",\"datePublished\":\"2023-03-22T16:04:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/\"},\"wordCount\":885,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005679\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/\",\"name\":\"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005679\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"datePublished\":\"2023-03-22T16:04:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005679\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230320005679\\\/en\\\/778437\\\/21\\\/GCP_Primarylarge_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/","og_locale":"en_US","og_type":"article","og_title":"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities - Pharma Trend","og_description":"\u2013 Funding Will Reach Under-Resourced Communities Impacted by the HIV Epidemic as Part of Gilead\u2019s Zeroing In\u2122: Ending the HIV Epidemic Grant Program \u2013 FOSTER CITY, Calif.&#8211;(BUSINESS WIRE)&#8211;Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is providing a total of $3 million in grant funding to eight organizations to provide services to communities disproportionately impacted ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-22T16:04:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities","datePublished":"2023-03-22T16:04:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/"},"wordCount":885,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/","url":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/","name":"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg","datePublished":"2023-03-22T16:04:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230320005679\/en\/778437\/21\/GCP_Primarylarge_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gilead-sciences-announces-3-million-in-grant-funding-to-eight-organizations-addressing-hiv-disparities-in-rural-u-s-communities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55096"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55096\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}